Granulocyte colony-stimulating factor enhances bone marrow mononuclear cell homing to the liver in a mouse model of acute hepatic injury

Digestive Diseases and Sciences

Volumn 55, Issue 10, 2010, Pages 2805-2813

  Jin, Shi Zhu ^a   Meng, Xiang Wei ^a   Sun, Xun ^a   Han, Ming Zi ^b   Liu, Bing Rong ^b   Wang, Xin Hong ^a   Sun, Li Ying ^b   Huang, Qi ^b   Zhao, Rui Bo ^b   Ban, Xiang ^b   Yu, Hong Ying ^b   Yu, Hong Wei ^b  

^a JILIN UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Acute liver failure; Autologous; Bone marrow mononuclear cell; Granulocyte colony stimulating factor; Mobilization; Transplantation

Indexed keywords

ALBUMIN; ANTIGEN; FLUORESCENT DYE; PKH 26; PROLIFERATIVE CELL NUCLEAR ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG; ALBUMINOID; CARBON TETRACHLORIDE; GRANULOCYTE COLONY STIMULATING FACTOR; ORGANIC COMPOUND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL HOMING; CELL ISOLATION; CELL LABELING; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; LIVER; LIVER FAILURE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; BIOPSY; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL; CELL MOTION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; PATHOLOGY; STEM CELL MOBILIZATION;

ALBUMINS; ANIMALS; BIOPSY; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CARBON TETRACHLORIDE; CELL MOVEMENT; CELLS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FLUORESCENT DYES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER FAILURE, ACUTE; MALE; MICE; MICE, INBRED BALB C; ORGANIC CHEMICALS;

EID: 77957899137     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-1117-5     Document Type: Article

References (26)

1. Masson S, Harrison DJ, Plevris JN, et al. Potential of hematopoietic stem cell therapy in hepatology: a critical review. Stem Cells. 2004;22:897-907.
2. Yannaki E, Athanasiou E, Xagorari A, et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol. 2005;33: 108-119.
3. Thorgeirsson SS, Grisham JW. Overview of recent experimental studies on liver stem cells. Semin Liver Dis. 2003;23: 303-312.
4. Tarella C, Zallio F, Caracciolo D, et al. Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patients. Stem Cells. 1999; 17:55-61.
5. Di Campli C, Piscaglia AC, Giuliante F, et al. No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure. Transplant Proc. 2005;37:2563-2566.
6. Gaia S, Smedile A, Omede P, et al. Feasibility and safety of GCSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol. 2006; 45:13-19.
7. Fukuhara S, Tomita S, Nakatani T, et al. G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes. Cell Transplant. 2004;13:741-748.
8. Anker PS, Noort WA, Scherjon SA, et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica. 2003;88: 845-852.
9. Jin SZ, Meng XW, Han MZ, et al. Stromal cell derived factor-1 enhances bone marrow mononuclear cell migration in mice with acute liver failure. World J Gastroenterol. 2009;15:2657-2664.
10. Petersen BE, Zajac VF, Michalopoulos GK. Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology. 1998;27: 1030-1038.
11. Sheikh AY, Lin SA, Cao F, et al. Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Stem Cells. 2007;25:2677-2684.
12. Okada S, Nakauchi H, Nagayoshi K, et al. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood. 1992;80:3044-3050.
13. Perin EC, Dohmann HF, Borojevic R, et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation. 2004;110:II213- II218.
14. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913-1918.
15. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364: 141-148.
16. Maga G, Hubscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci. 2003;116:3051-3060.
17. Grompe M. The role of bone marrow stem cells in liver regeneration. Semin Liver Dis. 2003;23:363-372.
18. Burgess AW, Metcalf D. The nature and action of granulocytemacrophage colony stimulating factors. Blood. 1980;56:947-958.
19. Dekker A, Bulley S, Beyene J, et al. Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation. J Clin Oncol. 2006;24:5207-5215.
20. Romanienko PJ, Camerini-Otero RD. Cloning, characterization, and localization of mouse and human SPO11. Genomics. 1999; 61:156-169.
21. Wexler SA, Donaldson C, Denning-Kendall P, et al. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol. 2003;121:368-374.
22. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrowderived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7: 430-436.
23. Sugano Y, Anzai T, Yoshikawa T, et al. Granulocyte colonystimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res. 2005;65: 446-456.
24. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood. 2005;106:1901-1910.
25. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 1996;382:635-638.
26. Gazitt Y, Akay C. Mobilization of myeloma cells involves SDF- 1/CXCR4 signaling and downregulation of VLA-4. Stem Cells. 2004;22:65-73.